Stroke care company Imperative Care Inc revealed on Friday the appointment of Daniel Davis as its chief operating officer.
In the senior position in the company, Davis is responsible for the launch and growth of the breakthrough technologies to treat ischemic stroke patients in the US.
Most recently, Davis has served as chief commercial officer and president of North America, Penumbra, where he launched the first FDA-cleared aspiration system for neurovascular mechanical thrombectomy.
The company said Davis brings 19 years of experience in sales, marketing, and business development with both early stage and Fortune 500 medical device, technology and consumer product companies, focused on bringing neurovascular innovations to market.
CrossBridge Bio to be acquired by Eli Lilly
FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer
EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
Lupin's Dapagliflozin Tablets launched in US market
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules